ABOUTNon-alcoholic fatty liver disease (NAFLD)NAFLD is currently the most common liver disorder both in the US and Europe. The fatty liver may progress to non-alcoholic steatohepatitis (NASH), which markedly increases the risk of cirrhosis and hepatocellular carcinoma. NAFLD is the hepatic manifestation of the metabolic syndrome and characterizes the majority of patients with type 2 diabetes.
Objectives1. To advance our understanding of the prevalence, diagnosis, pathogenesis, prevention and treatment of NAFLD.
2. To enable hepatologists and diabetologists and other specialists in cognate disciplines to interact. Guidelines for the NAFLD Study GroupThe NAFLD Study Group will follow the for Guidelines endorsed by the Executive Committee of the EASD (European Association for the Study of Diabetes) on 14 January 2013.
From 2018 to 2021, NAFLD was officially listed among the EASD Study Groups
YOUTUBE CHANNELThe presentations of the Study Groups Spring webinars posted online at the EGIR&NAFLD Study Groups YouTube channel
https://www.youtube.com/channel/UC-6sO4sxt-hwEnPfO9dyOIw Stay tune for fur next EVENT |
OUR NEXT ACTIVITIESMark your calendars!59th Annual EASD, October 2023The EASD Annual Meeting will be a hybrid event, providing the option to join in person in Hamburg, Germany or online via the Virtual Meeting platform.
NAFLD SYMPOSIUM at EASD: Tuesday, October 3, 2023 at 1:30 PM CEST, Chicago Hall Chairs: Paula Macedo, Catherine Postic
“Opening and update on the new nomenclature” A. Gastaldelli - Cardiometabolic Risk Lab., Institute of Clinical Physiology, CNR, Pisa, Italy “NAFLD and the diabetologist: how to screen it?” Cyrielle Caussy - Hôpital Lyon Sud, Département Endocrinologie, Diabète et Nutrition, Hospices Civils de Lyon, Lyon, France. “NAFLD and the diabetologist: new insights into pathophysiology” Hannele Yki Jarvinen – Department of Medicine, University of Helsinki, Helsinki University Hospital, Helsinki, Finland. “Genetically validated targets to treat fatty liver disease” Stefano Romeo - Department of Molecular and Clinical Medicine, The Sahlgrenska Academy, University of Gothenburg, Sweden. NAFLD STUDY GROUP VIRTUAL MEETING & ABSTRACTS SESSION with award 25-25 October, 2023LINKS |